29 CHEK2 del5395 is a founder mutation with no direct...

European Urology Supplements 2015 / 05 Vol. 14; Iss. 3

29 CHEK2 del5395 is a founder mutation with no direct effects for cancer risk in Latvian population

Plonis, J., Malevskis, A., Miculis, K., Kalniete, D., Nakazawa-Miklasevica, M., Aksenoka, K., Vaganovs, P., Irmejs, A., Pildava, S., Gardovskis, J., Miklasevics, E., Vjaters, E.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
14
Language:
english
Journal:
European Urology Supplements
DOI:
10.1016/s1569-9056(15)30028-2
Date:
May, 2015
File:
PDF, 61 KB
english, 2015
Conversion to is in progress
Conversion to is failed